Seven of every 100 patients in phase II cardiac rehab had resistant hypertension in a recent cohort study, and they ran higher long-term risks of hospitalization and death than the rest of the sample.
George Thomas, MD, explains the factors and risks associated with resistant hypertension and outlines management techniques for care at home and treatment resources provided by Cleveland Clinic.
An analysis of data from the Chronic Renal Insufficiency Cohort shows a high rate of treatment-resistant hypertension among chronic kidney disease patients, increasing their risk for adverse cardiovascular and renal outcomes. Screening and intervention are vital.
Resistant hypertension remains a leading cause of cardiovascular morbidity and mortality. Cleveland Clinic’s Resistant Hypertension Clinic offers diagnostic assessment, monitoring and clinical care. Clinical trials are evaluating potential new therapies.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
A trial studying renal denervation for resistant hypertension and a new Resistant Hypertension Clinic are advancing understanding of this condition.